glp 1 and biologics The World's First GCG/GLP-1 Dual Agonist The Therapeutic Potential of GLP-1

The pharmacokinetics of LY3437943 (retatrutide) support once-weekly administration due to an elimination half-life of approximately 6 days. Jastreboff AM et al., Nature Medicine, 2023 This extended half-life is made possible by attaching a fatty acid chain to the peptide, allowing it to bind to albumin a common protein in your blood that acts like a slow-release carrier

It is a central nervous system stimulant and controlled substance

With them, the medication becomes the accelerator

Support Your GLP-1 Therapy Journey Reduce Side Effects &amp

Have or have had an eating disorder, such as anorexia or bulimia

At the same time, new clinical findings show semaglutide may actually reduce alcohol cravings and drinking behavior in those with alcohol use disorder